(Q41513063)

1 October 2017

1 reference

title

Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management (English)

1 reference

1 October 2017

0 references

Massie BM

1

1 reference

PubMed ID

9200399

1 October 2017

Shah NB

series ordinal

2

1 reference

PubMed ID

9200399

1 October 2017

language of work or name

English

0 references

publication date

1 June 1997

1 reference

1 October 2017

American Heart Journal

1 reference

1 October 2017

133

1 reference

1 October 2017

703-712

1 reference

1 October 2017

6

1 reference

Trends in acute myocardial infarction and coronary heart disease death in the United States

1 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

Recent trends in acute coronary heart disease--mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

Heart failure: a growing public health problem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

Congestive heart failure: insights from epidemiology, implications for treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

The incidence and prevalence of congestive heart failure in Rochester, Minnesota.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

The Natural History of Congestive Heart Failure: The Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

Survival after the onset of congestive heart failure in Framingham Heart Study subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

Risk factors for heart failure in the general population: the study of men born in 1913

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

Prevalence and mortality rate of congestive heart failure in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

Left ventricular diastolic dysfunction as a cause of congestive heart failure. Mechanisms and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

Hospitalized congestive heart failure patients with preserved versus abnormal left ventricular systolic function: clinical characteristics and drug therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

Changing epidemiological features of cardiac failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

Spectrum and outcome of congestive heart failure in a hospitalized population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

Heart failure in the United States 1970-1985.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

Improving survival for patients with advanced heart failure: A study of 737 consecutive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

Changing mortality in dilated cardiomyopathy. The Heart Muscle Disease Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

Costs and effectiveness of angiotensin converting enzyme inhibition in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

Intensive home-care surveillance prevents hospitalization and improves morbidity rates among elderly patients with severe congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970173-X

10.1016/S0002-8703(97)70173-X

7 January 2021

Identifiers

DOI

1 reference

1 October 2017

1 reference

PubMed ID

9200399